Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;8(6):e1002652.
doi: 10.1371/journal.ppat.1002652. Epub 2012 Jun 7.

Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome

Affiliations

Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome

Paul V Licciardi et al. PLoS Pathog. 2012.
No abstract available

PubMed Disclaimer

Conflict of interest statement

I have read the journal's policy and have the following conflicts: MT is chairman of the Asia Pacific Immunoglobulins in Immunology Expert Group (APIIEG), which is supported by CSL Ltd and is a member of the Nestle Nutrition Institute Medical Advisory Board, Australia/New Zealand. All other authors declare they have no conflicts of interest.

Figures

Figure 1
Figure 1. Paradigm for the proposed biological effects of probiotic bacteria in protection against pneumococcal infection.
Commensal and/or probiotic bacteria can prevent pathogens (pneumococci) from attaching to and colonizing the respiratory epithelium by associating with specific cell surface receptors and by enhancing mucus secretion and the production of secretory IgA. Probiotic bacteria interact with underlying dendritic cells (DCs) which signal to the adaptive immune system to trigger a variety of effector cell types, including Th1, Th2, and Th17 as well as regulatory T cells and B cells depending on the local cytokine/chemokine microenvironment. Furthermore, probiotic bacteria also maintain the epithelial barrier integrity by upregulating the expression of specific tight junction proteins on damaged epithelium as a result of localized inflammatory responses following pathogen (pneumococcal) encounter and invasion. Refer to references – for more detail on probiotic–host effects. Th, T helper cell.

References

    1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. - PubMed
    1. Said MA, O'Brien KL, Nuorti JP, Singleton R, Whitney CG, et al. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine. 2011;29:5355–5362. - PubMed
    1. Jacups SP, Cheng A. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia–over 22 years. Vaccine. 2011;29:5386–5392. - PubMed
    1. Malley R. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med (Berl) 2010;88:135–142. - PubMed
    1. Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, et al. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clin Ther. 2008;30:341–357. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources